Research progress on the role of MZB1 in immune regulation.
MZB1 (Marginal Zone B and B1 Cell-Specific Protein), an endoplasmic reticulum-resident protein, has recently garnered significant attention for its role in immune regulation.
APA
Liu W, Jiang K, et al. (2026). Research progress on the role of MZB1 in immune regulation.. Frontiers in immunology, 17, 1741773. https://doi.org/10.3389/fimmu.2026.1741773
MLA
Liu W, et al.. "Research progress on the role of MZB1 in immune regulation.." Frontiers in immunology, vol. 17, 2026, pp. 1741773.
PMID
41635820
Abstract
MZB1 (Marginal Zone B and B1 Cell-Specific Protein), an endoplasmic reticulum-resident protein, has recently garnered significant attention for its role in immune regulation. As a critical modulator within various immune cells, MZB1 influences key processes such as cell differentiation, antibody production, and immune microenvironment dynamics. Despite advances in understanding, the precise mechanisms by which MZB1 contributes to immune homeostasis and dysregulation in pathological conditions remain incompletely defined. Emerging evidence highlights its involvement in tumor biology, inflammatory responses, and autoimmune diseases, positioning MZB1 as a potential therapeutic target. This review aims to synthesize current research findings on MZB1's functions across different immune cell types, elucidate its interactions with other immune regulatory factors, and explore its impact on the tumor microenvironment and immune-mediated disorders.
MeSH Terms
Humans; Animals; Tumor Microenvironment; Neoplasms; Autoimmune Diseases; Immunomodulation; Inflammation
같은 제1저자의 인용 많은 논문 (5)
- Neutrophils in nasopharyngeal carcinoma: from mechanisms to therapeutics.
- The application of mixed reality navigation system in robot-assisted radical prostatectomy for high-risk prostate cancer: a propensity score‑matched cohort study.
- CD146 pericyte-like lung cancer brain metastatic stem cells promote tumor angiogenesis through dual regulatory effects on the VEGF/VEGFR axis.
- Pharmacovigilance analysis of infliximab in inflammatory bowel disease: novel safety signals and sex-specific adverse event profiles from the FAERS database (2004-2024).
- Is a PERK-Regulated Long Non-Coding RNA That Fine-Tunes UPR Signalling and Inhibits Endoplasmic Reticulum Stress-Induced Cell Death.